bf/NASDAQ:RARE_icon.jpeg

COM:ULTRAGENYX

Ultragenyx Pharmaceutical Inc.

  • Stock

USD

Last Close

46.02

22/11 21:00

Market Cap

3.85B

Beta: -

Volume Today

593.87K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-35.07M
-
-59.80M
70.52%
-145.62M
143.50%
-245.87M
68.85%
-302.14M
22.88%
-197.61M
34.60%
-402.73M
103.80%
-186.57M
53.67%
-454.02M
143.36%
-707.42M
55.81%
-606.64M
14.25%
depreciation and amortization
444K
-
684K
54.05%
1.38M
102.34%
3.42M
147.40%
5.83M
70.12%
19.54M
235.42%
8.54M
56.30%
12.26M
43.59%
13.24M
7.98%
18.22M
37.62%
26.01M
42.73%
deferred income tax
6.16M
-
-16.25M
363.56%
-167.65M
931.97%
-18.94M
88.70%
-169.78M
796.44%
48.67M
128.67%
-1.64M
103.37%
-1.62M
1.22%
stock based compensation
657K
-
5.39M
721.00%
24.88M
361.33%
48.31M
94.14%
68.01M
40.79%
80.11M
17.78%
82.00M
2.36%
85.73M
4.56%
104.95M
22.41%
130.38M
24.23%
135.23M
3.72%
change in working capital
-1.54M
-
2.17M
240.19%
7.74M
257.16%
26.30M
239.99%
-20.23M
176.92%
-24.79M
22.53%
-15.94M
35.69%
104.66M
756.48%
-63.24M
160.42%
60.23M
195.25%
-15.10M
125.07%
accounts receivables
-7.58M
-
-20.10M
165.12%
9.84M
148.95%
-5.43M
155.20%
-12.07M
122.16%
-22.78M
88.75%
inventory
-5.28M
-
-4.45M
15.75%
-1.35M
69.76%
-3.12M
131.58%
-9.70M
211.23%
-6.93M
28.56%
accounts payables
237K
-
3.18M
1,240.51%
-1.98M
162.39%
2.50M
226.24%
3.46M
38.25%
3.37M
2.52%
20.65M
512.34%
29.60M
43.36%
2.81M
90.52%
87.44M
3,017.36%
2.38M
97.28%
other working capital
-1.78M
-
-1.01M
43.27%
9.72M
1,061.23%
23.80M
144.91%
-23.69M
199.54%
-15.30M
35.43%
-12.04M
21.31%
66.57M
653.07%
-57.49M
186.37%
-5.44M
90.54%
12.23M
324.84%
other non cash items
4.31M
-
6.92M
60.50%
5.64M
18.59%
700K
87.58%
10.93M
1,462%
-156K
101.43%
1.69M
1,184.62%
21.46M
1,168.50%
11.71M
45.46%
119.76M
923.09%
-12.68M
110.59%
net cash provided by operating activities
-31.20M
-
-44.63M
43.06%
-105.98M
137.44%
-160.97M
51.90%
-253.84M
57.69%
-290.57M
14.47%
-345.38M
18.87%
-132.22M
61.72%
-338.69M
156.16%
-380.46M
12.33%
-474.81M
24.80%
investments in property plant and equipment
-407K
-
-2.15M
428.01%
-4.96M
130.57%
-10.19M
105.61%
-2.79M
72.59%
-4.08M
45.94%
-24.83M
509.22%
-43.91M
76.81%
-73.09M
66.48%
-146.12M
99.91%
-46.77M
67.99%
acquisitions net
-142.80M
-
-11.79M
-
-75.03M
-
-2.50M
96.67%
purchases of investments
-63.95M
-
-208.97M
226.76%
-624.23M
198.71%
-442.49M
29.11%
-230.49M
47.91%
-509.80M
121.18%
-707.16M
38.71%
-850.30M
20.24%
-1.01B
19.04%
-614.74M
39.27%
-526.38M
14.37%
sales maturities of investments
16.60M
-
87.97M
429.93%
338.37M
284.63%
543.79M
60.71%
431.57M
20.64%
310.22M
28.12%
718.96M
131.76%
720.64M
0.23%
890.85M
23.62%
545.08M
38.81%
746.20M
36.90%
other investing activites
25K
-
-293K
1,272%
-1.54M
425.94%
-1.20M
22.00%
934K
177.70%
170.32M
18,135.76%
11.79M
93.08%
-5.55M
147.10%
-942K
83.04%
-844K
10.40%
-2.55M
201.90%
net cash used for investing activites
-47.73M
-
-123.44M
158.60%
-292.35M
136.84%
89.92M
130.76%
56.42M
37.26%
-33.33M
159.08%
-13.04M
60.88%
-179.12M
1,273.73%
-195.37M
9.07%
-291.65M
49.28%
168M
157.60%
debt repayment
-4.94M
-
-314.23M
-
-490.95M
-
common stock issued
171K
-
189.32M
110,611.70%
467.57M
146.98%
79.49M
83.00%
131.96M
66.02%
309.02M
134.18%
355.24M
14.96%
511.21M
43.91%
78.94M
84.56%
10.81M
86.30%
379.75M
3,412.02%
common stock repurchased
dividends paid
-4.35M
-
other financing activites
59.19M
-
9.25M
84.37%
27.83M
200.81%
638.30M
2,193.72%
89.06M
86.05%
39.61M
55.52%
981.35M
2,377.58%
8.39M
99.15%
net cash used provided by financing activities
171K
-
184.97M
108,070.18%
467.57M
152.78%
138.68M
70.34%
136.27M
1.74%
336.85M
147.20%
679.31M
101.66%
600.27M
11.63%
118.55M
80.25%
501.21M
322.77%
388.14M
22.56%
effect of forex changes on cash
-65K
-
528K
912.31%
-472K
189.39%
-165K
65.04%
1.12M
778.18%
-1.19M
206.70%
-1.07M
9.97%
462K
142.98%
net change in cash
-78.76M
-
16.90M
121.45%
69.25M
309.81%
67.55M
2.45%
-60.63M
189.76%
12.48M
120.59%
320.72M
2,469.04%
290.05M
9.56%
-416.71M
243.67%
-171.98M
58.73%
85.59M
149.77%
cash at beginning of period
86.19M
-
7.43M
91.38%
24.32M
227.51%
93.57M
284.68%
161.12M
72.19%
103.04M
36.05%
115.53M
12.12%
436.24M
277.62%
726.29M
66.49%
309.58M
57.37%
133.81M
56.78%
cash at end of period
7.43M
-
24.32M
227.51%
93.57M
284.68%
161.12M
72.19%
100.49M
37.63%
115.53M
14.96%
436.24M
277.62%
726.29M
66.49%
309.58M
57.37%
137.60M
55.55%
219.40M
59.45%
operating cash flow
-31.20M
-
-44.63M
43.06%
-105.98M
137.44%
-160.97M
51.90%
-253.84M
57.69%
-290.57M
14.47%
-345.38M
18.87%
-132.22M
61.72%
-338.69M
156.16%
-380.46M
12.33%
-474.81M
24.80%
capital expenditure
-407K
-
-2.15M
428.01%
-4.96M
130.57%
-10.19M
105.61%
-2.79M
72.59%
-4.08M
45.94%
-24.83M
509.22%
-43.91M
76.81%
-73.09M
66.48%
-146.12M
99.91%
-46.77M
67.99%
free cash flow
-31.61M
-
-46.78M
48.01%
-110.93M
137.12%
-171.16M
54.30%
-256.64M
49.94%
-294.64M
14.81%
-370.21M
25.65%
-176.13M
52.43%
-411.79M
133.80%
-526.59M
27.88%
-521.57M
0.95%

All numbers in USD (except ratios and percentages)